Companies / Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc.
Nasdaq: ZVRACIK 1434647BOSTON, MA
Financials · FY2015
Ownership
59.4M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 1.11% | 662,135 |
| Institutions | 65.62% | 38,967,838 |
| Public float | 33.26% | 19,753,808 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
McFarlane Neil F.CEOPresident and CEO · Director | 0.65% | 387,225 |
| 0.24% | 143,515 | |
Bode John BDirector | 0.21% | 123,400 |
| 0.10% | 62,278 | |
Thompson RahsaanChief Legal & Compliance | 0.08% | 49,919 |
Sangiovanni Timothy J.SVP, Finance & Corp Controller | 0.05% | 29,590 |
Quartel Adrian WChief Medical Officer | 0.02% | 9,723 |
Favorito Tamara aDirector | — | — |
| — | — |
Institutional holders 164
View all →| Holder | Value | % of shares |
|---|---|---|
| $73.26M | 8.60% | |
| $30.92M | 5.81% | |
| $29.61M | 5.57% | |
| $24.12M | 2.83% | |
| $21.45M | 4.03% | |
| $15.88M | 2.98% | |
| $12.79M | 2.31% | |
| $10.37M | 1.95% | |
| $9.84M | 1.85% | |
| $8.11M | 1.52% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | McFarlane Neil F. CEO | Sell | Common Stock | $853.4K | -91K -19.98% | 364,350 0.61% of shares | medium |
| Dec 31, 2025 | Clifton R. LaDuane | Other | Common Stock | $434.7K | -49K -25.26% | 143,515 0.24% of shares | low |
| Mar 24, 2026 | Bode John B Director | Exercise | Common Stock | $194.8K | +39K +87.11% | 84,200 0.14% of shares | low |
| Mar 24, 2026 | Bode John B Director | Exercise | Common Stock | $191.7K | +39K +46.56% | 123,400 0.21% of shares | low |
| Feb 9, 2026 | McFarlane Neil F. CEO | Sell | Common Stock | $125.2K | -15K -3.64% | 387,225 0.65% of shares | medium |
| Feb 3, 2026 | Schafer Joshua Executive | Sell | Common Stock | $96.5K | -11K -14.43% | 62,278 0.10% of shares | low |
| Jan 30, 2026 | Quartel Adrian W Executive | Sell | Common Stock | $40.0K | -5K -31.80% | 9,723 0.02% of shares | low |
| Jan 30, 2026 | Thompson Rahsaan Executive | Sell | Common Stock | $36.0K | -4K -7.56% | 49,919 0.08% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ZVRA | — | 488445206 |